| Term 
 | Definition 
 
        | 
Inhibit Thromboxane synthesis (Cox1 inhibitor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibits phosphodiesterase↑cAMP↓ TXA2 production.Blocks platelet adhesion to vessels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit ADP binding to platelet receptor (irreversible) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds Antithrombin III, ↑ activity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
(+) neutralizes (-) Heparin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks vitamin KInhibit synthesis of factors & anticoagulent proteins. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds & blocks thrombinfor patients with heparin induced thrombocytopenia. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds and activates plasminogen(Antigenic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds and activates plasminogen(non-antigenic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
causes plasminogen to have greater affinity for fibrin. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
competatively inhibits plasminogen activationcounters fibrinolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Phytonadione (Aquamephyton) (vitamin K) |  | Definition 
 
        | 
Counter CoumadinNewborn hemorrhagic disease |  | 
        |  |